ATE491475T1 - Konjugate enthaltend gm-csf und ein polymer - Google Patents

Konjugate enthaltend gm-csf und ein polymer

Info

Publication number
ATE491475T1
ATE491475T1 AT05771041T AT05771041T ATE491475T1 AT E491475 T1 ATE491475 T1 AT E491475T1 AT 05771041 T AT05771041 T AT 05771041T AT 05771041 T AT05771041 T AT 05771041T AT E491475 T1 ATE491475 T1 AT E491475T1
Authority
AT
Austria
Prior art keywords
conjugates
csf
polymer
conjugates containing
methods
Prior art date
Application number
AT05771041T
Other languages
English (en)
Inventor
Mary Bossard
Ping Zhang
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Application granted granted Critical
Publication of ATE491475T1 publication Critical patent/ATE491475T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT05771041T 2004-07-16 2005-07-14 Konjugate enthaltend gm-csf und ein polymer ATE491475T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58860104P 2004-07-16 2004-07-16
PCT/US2005/025052 WO2006019950A2 (en) 2004-07-16 2005-07-14 Conjugates of a gm-csf moiety and a polymer

Publications (1)

Publication Number Publication Date
ATE491475T1 true ATE491475T1 (de) 2011-01-15

Family

ID=35565892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05771041T ATE491475T1 (de) 2004-07-16 2005-07-14 Konjugate enthaltend gm-csf und ein polymer

Country Status (12)

Country Link
US (2) US20060036080A1 (de)
EP (1) EP1768700B1 (de)
JP (1) JP2008506704A (de)
KR (1) KR101330338B1 (de)
CN (1) CN101031323A (de)
AT (1) ATE491475T1 (de)
AU (1) AU2005275108B2 (de)
CA (1) CA2573262C (de)
DE (1) DE602005025355D1 (de)
ES (1) ES2355642T3 (de)
MX (1) MX2007000568A (de)
WO (1) WO2006019950A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007009208A1 (en) * 2005-06-02 2007-01-25 Cangene Corporation Poly(ethylene glocol) modified human gm-csf with increased biological activity
CU23556A1 (es) * 2005-11-30 2010-07-20 Ct Ingenieria Genetica Biotech Estructura polimérica semejante a dendrímero para la obtención de conjugados de interés farmacéutico
US8309680B2 (en) * 2006-02-21 2012-11-13 Nektar Therapeutics Segmented degradable polymers and conjugates made therefrom
EP1834963A1 (de) * 2006-03-13 2007-09-19 Siegfried Ltd. Di-Polymer-Konjugate von Proteinen und Verfahren zur deren Erstellung
WO2008019214A1 (en) 2006-08-04 2008-02-14 Prolong Pharmaceuticals, Inc. Modified erythropoietin
ITMI20061624A1 (it) 2006-08-11 2008-02-12 Bioker Srl Mono-coniugati sito-specifici di g-csf
JP2008069073A (ja) * 2006-09-12 2008-03-27 Yokohama Tlo Co Ltd ラクトフェリン複合体及びその製造方法
CA2723821C (en) * 2008-05-16 2017-05-02 Nektar Therapeutics Conjugates of a cholinesterase moiety and a polymer
CA2737040C (en) 2008-09-19 2017-05-02 Nektar Therapeutics Polymer conjugates of therapeutic peptides
WO2010033221A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of protegrin peptides
US20110165113A1 (en) * 2008-09-19 2011-07-07 Nektar Therapeutics Polymer conjugates of v681-like peptides
TW201808987A (zh) * 2016-06-08 2018-03-16 健生生物科技公司 Ｇｍ－ｃｓｆ變體及使用方法
KR101947342B1 (ko) * 2017-05-05 2019-02-12 주식회사 유비프로틴 Gm-csf 반감기를 증가시키는 방법

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908763A (en) * 1984-07-06 1999-06-01 Novartis Corporation DNA encoding GM-CSF and a method of producing GM-CSF protein
US5391485A (en) * 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
US5214131A (en) * 1988-05-06 1993-05-25 Sumitomo Pharmaceuticals Company, Limited Polyethylene glycol derivatives, modified peptides and production thereof
JP2958019B2 (ja) * 1988-05-06 1999-10-06 住友製薬株式会社 ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法
US5349052A (en) * 1988-10-20 1994-09-20 Royal Free Hospital School Of Medicine Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
GB8824591D0 (en) * 1988-10-20 1988-11-23 Royal Free Hosp School Med Fractionation process
DE69026306T2 (de) * 1989-05-27 1996-10-17 Sumitomo Pharma Verfahren für die Herstellung von Polyethylenglykolderivate und modifizierte Proteine.
US5109119A (en) * 1989-06-06 1992-04-28 Schering Corporation Crystalline r-h-gm-csf and method
AU1462392A (en) * 1991-02-22 1992-09-15 Amgen, Inc. Use of gm-csf and g-csf to promote accelerated wound healing
GB9317618D0 (en) * 1993-08-24 1993-10-06 Royal Free Hosp School Med Polymer modifications
WO1995026746A1 (en) * 1994-03-31 1995-10-12 Amgen Inc. Compositions and methods for stimulating megakaryocyte growth and differentiation
US5629384A (en) * 1994-05-17 1997-05-13 Consiglio Nazionale Delle Ricerche Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
ATE200030T1 (de) * 1997-01-29 2001-04-15 Polymasc Pharmaceuticals Plc Pegylationsverfahren
US6548644B1 (en) * 1997-03-10 2003-04-15 Immunex Corporation Site protected protein modification
BR9812267B1 (pt) * 1997-07-14 2013-11-26 Hormônio de crescimento recombinante.
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
ATE367398T1 (de) * 2000-05-16 2007-08-15 Bolder Biotechnology Inc Verfahren zur rückfaltung von proteinen mit freien cysteinresten
AR032757A1 (es) * 2000-06-30 2003-11-26 Smithkline Beecham Corp Composiciones biologicamente activas de conjugados de quimioquina, uso de dichas composiciones en la fabricacion de composiciones farmaceuticas, metodo para preparar dichas composiciones, y metodos para mejorar la farmacocinetica de una quimioquina
ATE537845T1 (de) * 2000-10-31 2012-01-15 Pr Pharmaceuticals Inc Verfahren zur herstellung von formulierungen zur verbesserten abgabe von bioaktiven molekülen
US20020142964A1 (en) * 2000-11-02 2002-10-03 Nissen Torben Lauesgaard Single-chain polypeptides
JP4758608B2 (ja) * 2001-11-07 2011-08-31 ネクター セラピューティックス 分枝ポリマーおよびそれらの結合体
WO2004012773A1 (en) * 2002-07-24 2004-02-12 F. Hoffmann-La Roche Ag Polyalkylene glycol acid additives
AU2003265523A1 (en) * 2002-08-20 2004-03-11 Genitrix, Llc Lectin compositions and methods for modulating an immune response to an antigen
RS20050202A (en) * 2002-09-09 2007-08-03 Nektar Therapeuticals Al.Corporation, Water-soluble polymer alkanals
EA013535B1 (ru) * 2002-12-26 2010-06-30 Маунтин Вью Фамэсьютикэлс, Инк. Полимерный конъюгат биоактивного компонента (варианты), способ его получения и использования, фармацевтические продукты на его основе
US7208145B2 (en) * 2002-12-31 2007-04-24 Nektar Therapeutics Al, Corporation Polymeric reagents comprising a ketone or a related functional group
NZ541374A (en) * 2003-05-23 2008-09-26 Nektar Therapeutics Al Corp PEG derivatives having an amidocarbonate linkage

Also Published As

Publication number Publication date
DE602005025355D1 (de) 2011-01-27
EP1768700A2 (de) 2007-04-04
CA2573262C (en) 2015-02-10
MX2007000568A (es) 2007-03-30
WO2006019950A3 (en) 2006-08-03
ES2355642T3 (es) 2011-03-29
US20060036080A1 (en) 2006-02-16
AU2005275108B2 (en) 2011-05-12
AU2005275108A1 (en) 2006-02-23
CN101031323A (zh) 2007-09-05
EP1768700B1 (de) 2010-12-15
US20140044672A1 (en) 2014-02-13
KR101330338B1 (ko) 2013-11-15
WO2006019950A2 (en) 2006-02-23
KR20070043852A (ko) 2007-04-25
JP2008506704A (ja) 2008-03-06
CA2573262A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
ATE491475T1 (de) Konjugate enthaltend gm-csf und ein polymer
MX2008001706A (es) Conjugados de una porcion g-csf y un polimero.
WO2004075923A3 (en) Polymer-factor viii moiety conjugates
WO2006005058A3 (en) Polymer-factor ix moiety conjugates
RS20050263A (en) Polymer conjugates with decreased antigenicity,methods of preparation and uses thereof
NZ538624A (en) Water-soluble polymer alkanals
TW200635576A (en) Releasable polymeric conjugates based on aliphatic biodegradable linkers
WO2004108070A3 (en) Releasable polymeric conjugates based on aliphatic biodegradable linkers
EP2279758A3 (de) Konjugate mit abbaubarer Verknüpfung und Polymerreagenzien zur Herstellung dieser Konjugate
GB2436996B (en) Rigid amines
EP1988910A4 (de) Acryloyloxyethylphosphorylcholin-haltige polymerkonjugate und ihre zubereitung
SE0401971D0 (sv) Piperidne derivatives
BRPI0409133A (pt) formulações farmacêuticas contendo metilnaltrexona
WO2006138463A3 (en) Polymer-based compositions and conjugates of non-steroidal anti-inflammatory drugs
WO2005089805A3 (en) Polymer-based compositions and conjugates of hiv entry inhibitors
WO2007127440A3 (en) Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
WO2006102659A3 (en) CONJUGATES OF AN hGH MOIETY AND A POLYMER
WO2009139905A3 (en) Conjugates of a cholinesterase moiety and a polymer
WO2006089228A3 (en) Conjugates of an epo moiety and a polymer
WO2010080720A3 (en) Conjugates of a lysosomal enzyme moiety and a water soluble polymer
WO2007117685A3 (en) Conjugates of an anti-tnf-alpha antibody
SE0303280D0 (sv) Novel compounds
DE60209795D1 (de) Zusammensetzungen enthaltend endgruppen-verkappte polyalkylenglykole
TNSN05095A1 (en) Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
CY1115680T1 (el) Προϊοντα συζευξης πολυμερους με μειωμενη αντιγονικοτητα, μεθοδοι παρασκευης και χρησεις αυτων

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties